Dopamine D3 Receptor Occupancy in Bipolar Depression

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 6, 2026

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions

Bipolar Depression

Interventions

DRUG

Cariprazine

Participants will receive 6 weeks of cariprazine treatment

Trial Locations (1)

Columbia University Medical Center, New York

All Listed Sponsors

lead

New York State Psychiatric Institute

OTHER